PhosImmune's Acquisition

PhosImmune was acquired by Agenus on December 23, 2015.

PhosImmune is a cancer immunotherapy company that was founded to commercialize a library of phosphopeptide tumor targets (PTTs) discovered at the University of Virginia and the University of Birmingha…

Articles about PhosImmune's Acquisition: